Stereoselective Synthesis of Photoreactive Sesquiterpene Lactones
FULL PAPER
(15ϫ8 mL). After concentration of the combined organic layers,
the white solid was dissolved in toluene (400 mL). After 30 min of
azeotropic distillation, the mixture was cooled to room tempera-
ture, washed with saturated aqueous NaHCO3 (2ϫ 50 mL) and
brine (2ϫ20 mL), dried with MgSO4 and concentrated in vacuo.
The white solid (–)-2c was obtained with good purity (469 mg, 95%
yield) or could be further purified by flash chromatography over
silica gel (pentane/diethyl ether, 7:3, 82% yield). M.p. 30–32 °C.
[α]2D0 = –83.3 (c = 0.5, CHCl3), ref.[13b] [α]1D8 = –93 (c = 2.034,
CHCl3, 98.4% ee), ref.[24b] [α]2D3 = –77.6 (c = 4.6, CHCl3, pure). The
diastereomer could not be detected by NMR spectroscopy. 1H
[1]
J. C. Mitchell, G. Dupuis, Br. J. Dermatol. 1971, 84, 139–150.
[2] a) E. Rodriguez, G. H. N. Towers, J. C. Mitchell, Phytochemis-
try 1976, 15, 1573–1580; b) J. C. G. Galindo, A. Hernández,
F. E. Dayan, M. R. Tellez, F. A. Macias, R. N. Paul, S. O.
Duke, Phytochemistry 1999, 52, 805–813.
[3] a) K.-H. Lee, T. Ibuka, R.-Y. Wu, T. A. Geissman, Phytochem-
istry 1977, 16, 1177–1181; b) A. Meyer, S. Zimmermann, B.
Hempel, P. Imming, J. Nat. Prod. 2005, 68, 432–434; c) V. Saro-
glou, A. Karioti, C. Demetzos, K. Dimas, H. Skaltsa, J. Nat.
Prod. 2005, 68, 1404–1407.
[4] a) V. M. Dirsch, H. Stuppner, E. P. Ellmerer-Müller, A. M.
Vollmar, Bioorg. Med. Chem. 2000, 8, 2747–2753; b) P.
Rüngeler, V. Castro, G. Mora, N. Gören, W. Vichnewski, H. L.
Pahl, I. Merfort, T. J. Schmidt, Bioorg. Med. Chem. 1999, 7,
2343–2352.
[5] a) S. M. Kupchan, D. C. Fessler, M. A. Eakin, T. J. Giacobbe,
Science 1970, 168, 376–378; b) I. H. Hall, K.-H. Lee, C. O.
Starnes, S. A. Eigebaly, T. Ibuka, Y.-S. Wu, T. Kimura, M.
Haruna, J. Pharm. Sci. 1978, 67, 1235–1239; c) P.-R. Huang,
Y.-M. Yeh, T.-C. V. Wang, Cancer Lett. 2005, 227, 169–174; d)
J. Merten, A. Hennig, P. Schwab, R. Fröhlich, S. V. Tokalov,
H. O. Gutzeit, P. Metz, Eur. J. Org. Chem. 2006, 1144–1161.
[6] a) T. J. Schmidt, Bioorg. Med. Chem. 1997, 5, 645–653; b) F. F.
Tukov, S. Anand, R. S. V. S. Gadepalli, A. A. L. Gunatilaka,
J. C. Matthews, J. M. Rimoldi, Chem. Res. Toxicol. 2004, 17,
1170–1176.
NMR (300 MHz, CDCl3): δ = 3.78 (ddd, J1 = J2 = 11 Hz, J3
3.8 Hz, 1 H, 7a-H), 2.50 (B part of an ABX system, JAB = 16.2 Hz,
JBX = 6.2 Hz, 1 H, 3-H), 2.22 (A part of an ABX system, JAB
=
=
16.2 Hz, JAX = 13.0 Hz, 1 H, 3-H), 2.00–1.20 (m, 9 H, 3a-H and 8
H cyclohexane) ppm. 13C NMR (75 MHz, CDCl3): δ = 177.6
(C=O), 85.2 (C-7a), 44.8 (C-3a), 35.9 (C-3), 30.3 (CH2), 28.3 (CH2),
25.3 (CH2), 24.1 (CH2) ppm.
(+)-(3aS,7aR)-Hexahydro-benzofuran-2-one (2d): The same pro-
cedure as for (–)-2c starting from (–)-12b (1.36 g, 3.58 mmol) gave
(+)-2d as a white solid (409 mg, 82 % yield after purification).
[α]2D0 = +84.3 (c = 1.8, CHCl3), ref.[13b] [α]1D8 = +88 (c = 2.044,
CHCl3, 96.8% ee), ref.[24b] [α]2D3 = +78.5 (c = 2.9, CHCl3, pure).
The diastereomer could not be detected by NMR spectroscopy.
[7] E. Giménez-Arnau, C. Bussey, J.-P. Lepoittevin, Photochem.
Photobiol. 1997, 65, 316–322.
[8] a) E. Giménez-Arnau, S. Mabic, J.-P. Lepoittevin, Chem. Res.
Toxicol. 1995, 8, 22–26; b) V. Berl, J.-P. Lepoittevin, Pho-
tochem. Photobiol. 1999, 69, 653–657.
[9] a) H. Du Peloux Menagé, J. S. Ross, P. G. Norris, J. L. M.
Hawk, I. R. White, Br. J. Dermatol. 1995, 132, 543–547; b) H.
Du Peloux Menagé, J. L. M. Hawk, I. R. White, Contact Der-
matitis 1998, 39, 119–122.
[10] a) C. Benezra, J.-L. Stampf, P. Barbier, G. Ducombs, Contact
Dermatitis 1985, 13, 110–114; b) M. Schaeffer, P. Talaga, J.-L.
Stampf, C. Benezra, Contact Dermatitis 1990, 22, 32–36.
[11] For a review see: a) P. A. Grieco, Synthesis 1975, 67–82; b)
H. M. R. Hoffmann, J. Rabe, Angew. Chem. Int. Ed. Engl.
1985, 24, 94–110; c) N. Petragnagni, H. M. C. Ferraz, G. V. J.
Silva, Synthesis 1986, 157–183.
[12] a) M. D. Mihovilovic, P. Kapitan, J. Rydz, F. Rudroff, F. H.
Ogink, M. W. Fraaije, J. Mol. Catal. B 2005, 32, 135–140; b)
A. Watanabe, T. Uchida, R. Irie, T. Katsuki, Proc. Natl. Acad.
USA 2004, 101, 5737–5742.
[13] a) C. Forzato, R. Gandolfi, F. Molinari, P. Nitti, G. Pitacco,
E. Valentin, Tetrahedron: Asymmetry 2001, 12, 1039–1046; b)
M. Ganaha, Y. Funabiki, M. Motoki, S. Yamauchi, Y. Kinosh-
ita, Biosci. Biotechnol. Biochem. 1998, 62, 181–184.
[14] a) P. Müller, F. Lacrampe, G. Bernardinelli, Tetrahedron:
Asymmetry 2003, 14, 1503–1510; b) M. P. Doyle, J. Colyer, J.
Mol. Catal. A 2003, 196, 93–100.
α-Methylenation of Lactones with a trans Ring Junction [(–)-2c and
(+)-2d]: The lactones (–)-2c and (+)-2d (ee Ն 98%) were converted
into the corresponding α-methylene-γ-butyrolactones (–)-1c and
(+)-1d, respectively, according to the procedure described by Grieco
and coworkers:[11a] methylation [purification by flash chromatog-
raphy over silica gel, pentane/diethyl ether (90:10), 92% yield], fol-
lowed by an α-selenylation and direct oxidation [purification by
flash chromatography over silica gel, hexane/ethyl acetate (85:15),
70% yield for the 2 steps].
(3aR,7aS)-3-Methyl-hexahydrobenzofuran-2-one (13c) and
(3aS,7aR)-3-Methyl-hexahydrobenzofuran-2-one (13d): Colourless
1
oil. H NMR (300 MHz, CDCl3): δ = 3.96 (ddd, J1 = J2 = 11 Hz,
J3 = 3.8 Hz, 1 H, 7a-H), 2.62 (qd, J1 = J2 = 7.6 Hz, 1 H, 3-H),
2.26–2.22 (m, 1 H, 3a-H), 2.00–1.70 (m, 4 H, CH2 cyclohexane),
1.60–1.16 (m, 4 H, CH2 cyclohexane), 1.15 (d, J = 7.6 Hz, 3 H,
CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 180.1 (C=O), 81.8
(C-7a), 47.3 (C-3a), 38.8 (C-3), 30.6 (CH2), 25.2 (CH2), 24.6 (CH2),
24.0 (CH2), 9.6 (C-8) ppm.
(–)-(3aR,7aS)-3-Methylene-trans-hexahydrobenzofuran-2(3H)-one
(1c): White solid. M.p. 60 °C, ee Ն 98%. [α]2D0 = –60.0 (c = 1.7,
1
CHCl3). H NMR (300 MHz, CDCl3): δ = 6.04 (d, J = 3.2 Hz, 1
H, 8-H), 5.36 (d, J = 3.2 Hz, 1 H, 8-H), 3.69 (ddd, J1 = J2
=
11.1 Hz, J3 = 3.5 Hz, 1 H, 7a-H), 2.44–2.34 (m, 1 H, 3a-H), 2.28–
2.21 (m, 1 H), 2.15–2.09 (m, 1 H), 1.98–1.82 (m, 2 H), 1.67–1.54
(m, 1 H), 1.44–1.29 (m, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ
= 170.6 (C=O), 139.6 (C-3), 117.1 (C-8), 83.1 (C-7a), 48.9 (C-3a),
30.5 (CH2), 25.8 (CH2), 24.9 (CH2), 24.0 (CH2). C9H12O2 (152.19):
calcd. C 71.03, H 7.95; found C 70.92, H 8.03.
[15] H. J. Dauben, L. L. McCoy, J. Am. Chem. Soc. 1959, 81, 4863–
4873.
[16] a) A. Tenaglia, A. Heumann, Angew. Chem. Int. Ed. 1999, 38,
2180–2184; b) A. Pfaltz, Chimia 2001, 55, 708–714.
[17] B. M. Trost, D. L. Van Vranken, R. C. Bunt, US Patent 1998,
US5739396, 14 pages.
(+)-(3aS,7aR)-3-Methylene-trans-hexahydrobenzofuran-2(3H)-one
(1d): White solid. M.p. 61 °C, ee Ն 98%. [α]2D0 = +59.5 (c = 1.9,
CHCl3). C9H12O2 (152.19): calcd. C 71.03, H 7.95; found C 70.90,
H 8.15.
[18]
[19]
[20]
G. C. Lloyd-Jones, S. C. Stephen, Chem. Eur. J. 1998, 4, 2539–
2549.
B. M. Trost, R. C. Bunt, J. Am. Chem. Soc. 1994, 116, 4089–
4090.
A. Saitoh, M. Misawa, T. Morimoto, Tetrahedron: Asymmetry
1999, 10, 1025–1028.
Acknowledgments
[21]
[22]
A. P. Krapcho, Synthesis 1982, 805–822.
P. Sennhenn, B. Gabler, G. Helmchen, Tetrahedron Lett. 1994,
35, 8595–8598.
The authors thank the French Ministère de l’Education Nationale,
[23]
de la Recherche et de la Technologie for a fellowship to S. F.
J. M. Berge, S. M. Roberts, Synthesis 1979, 471–472.
Eur. J. Org. Chem. 2007, 1145–1152
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1151